Page last updated: 2024-10-28

haloperidol and Bladder Disorder, Neurogenic

haloperidol has been researched along with Bladder Disorder, Neurogenic in 2 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaidyanathan, S1
Rao, MS1
Bapna, BC1
Sharma, PL1
Chary, KS1
Swamy, RP1
Yokoyama, O1
Yoshiyama, M1
Namiki, M1
de Groat, WC1

Other Studies

2 other studies available for haloperidol and Bladder Disorder, Neurogenic

ArticleYear
Further observations on vesicourethral dopamine receptors--a urodynamic study with haloperidol.
    Annals of clinical research, 1980, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Electromyography; Female; Haloperidol; Humans; Male; Middle Aged; Pressure;

1980
Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion.
    The American journal of physiology, 1999, Volume: 276, Issue:4

    Topics: Animals; Arterial Occlusive Diseases; Benzazepines; Cerebral Infarction; Cerebrovascular Disorders;

1999